Inactive Instrument

INSTEM

Equities

INS

GB00B3TQCK30

AIM WINNERS & LOSERS: TomCo raises funds; Instem bid "final"

October 13, 2023 at 05:54 am EDT

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

TomCo Energy PLC, up 19% at 0.065 pence, 12-month range 0.050-0.54p. The US-focused oil development firm raises gross proceeds of GBP100,000 via a subscription of 125.0 million shares at 0.08p each - a 46% premium to Thursday's closing price of 0.055p. Says subscription is within existing shareholder, and shares represent around 3.9% of its enlarged share capital. Will use funds cover costs of developing Tar Sands Holdings II in Utah, via its Greenfield Energy subsidiary.

----------

Ondine Biomedical Inc, up 10% at 8.00p, 12-month range 6.86p-29.19p. The Vancouver-based life sciences company says its Steriwave technology is now available in hospitals across Canada, with Nova Scotia's largest hospital Queen Elizabeth II Health Sciences Centre in Nova Scotia now becoming the latest facility to implement the spray. Steriwave employs patented nasal photodisinfection technology to eliminate bacteria, fungi and viruses located on human tissues. "It is hugely satisfying that Steriwave is now available in hospitals from coast to coast across Canada, giving patients enhanced protection against post-surgical infections," says CEO Carolyn Cross.

----------

AIM - LOSERS

----------

Instem PLC, down 6.9% at 761.50p, 12-month range 580p-835.56p. Specialist healthcare industry investor Archimed SAS confirms its final offer for the life sciences IT company is 833p per share, valuing Instem at just over GBP200 million. The offer will not be increased, Archimed says. Instem had agreed to the private equity buyout at the end of August. The court and general meetings to approve the deal are scheduled for next Thursday.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Stocks mentioned in the article

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
BRENT CRUDE OIL SPOT	88.07 USD	+0.10%	+1.75%	-
WTI	83.53 USD	0.00%	+1.68%	-
ONDINE BIOMEDICAL INC.	5.875 GBX	0.00%	-12.96%	16.59M
TOMCO ENERGY PLC	0.0385 GBX	0.00%	+1.32%	1.85M

Latest news about INSTEM

Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline	Jan. 25	CI
Instem Delists from London Bourse's AIM After Merger with ArchiMed	Nov. 21	MT
France's Archimed Completes Acquisition of UK's Instem	Nov. 20	MT
Instem plc Announces Board Resignations	Nov. 20	CI
ArchiMed SAS agreed completed the acquisition of Instem plc (AIM : INS) from group of sellers.	Nov. 19	CI
Instem acquisition by Ichor sanctioned by UK court	Nov. 16	AN
UK Court Clears Archimed’s Takeover of Instem	Nov. 16	MT
Actual Experience appoints administrators	Nov. 07	AN
Instem's Acquisition by Archimed's Ichor Management Granted UK Regulatory Nod	Nov. 07	MT
Instem shareholders back motions relating to Archimed offer	Nov. 03	AN
Instem, Archimed’s Ichor Management Agree Acquisition Deal Price	23-10-30	MT
Instem Postpones Court, General Meetings for Archimed Bid as New Suitors Surface	23-10-20	MT
Instem adjourns meeting after disclosing further approaches	23-10-18	AN
Instem shares fall back as Archimed says offer is final	23-10-13	AN
AIM WINNERS & LOSERS: TomCo raises funds; Instem bid "final"	23-10-13	AN
Archimed's Ichor Management Says GBP203 Million Cash Offer for Instem is Final	23-10-13	MT
Instem's second-largest shareholder opposes deal with PE firm Archimed	23-09-28	RE
Instem swings to loss in first half but posts revenue growth	23-09-15	AN
Instem plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-15	CI
Fears for the Chinese economy weigh on the FTSE 100	23-08-31
FTSE 100 Ends Higher, Helped by Hopes of US Rate Pause	23-08-30	DJ
UK Net Mortgage Approvals Fall As Interest Rates Remain High	23-08-30	DJ
FTSE 100 outperforms European peers	23-08-30	AN
AIM WINNERS & LOSERS: Instem soars on GBP200 million takeover	23-08-30	AN
Prudential outperforms; Instem jumps on takeover	23-08-30	AN

Chart INSTEM

Duration

Period

More charts

Company Profile

Instem plc is a United Kingdom-based company that is a provider of information technology (IT) solutions to the global life sciences market. The Company operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trial Acceleration. Study Management Solutions offers software that enables organizations to collect, review, manage and report discovery and preclinical data. Regulatory Solutions provides software, outsourced services and consulting for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The Company's In Silico Solutions enable researchers to generate scientific insights through the identification, extraction and analysis of information. Clinical Trials Acceleration Solutions offers technology solutions and consulting services to facilitate data integration, statistics, analytics and insights for companies of any size or stage of clinical trial analysis.

Sector

More about the company